Drug Repositioning: Current Advances and Future Perspectives
Drug repositioning is the process of identifying new indications for existing drugs. At present, the conventional de novo drug discovery process requires an average of about 14 years and US$2.5 billion to approve and launch a drug. Drug repositioning can reduce the time and cost of this process beca...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Andere auteurs: | |
| Formaat: | Elektronisch Hoofdstuk |
| Taal: | Engels |
| Gepubliceerd in: |
Frontiers Media SA
2019
|
| Reeks: | Frontiers Research Topics
|
| Onderwerpen: | |
| Online toegang: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|